J&J, wholesalers see an end to their opioid liability hangover
pharmaphorum
FEBRUARY 28, 2022
Johnson & Johnson and the ‘big three’ US pharm wholesalers say they are close to finalising a $26 billion settlement that could allow them to finally put years of litigation over their role in fuelling the opioid crisis behind them. spike in deaths in the 12 months to April 2021 to nearly 100,000.
Let's personalize your content